Evidence map›Paper›PMID 42390675›Full record

ArticleEuropean journal of pediatrics2026

Gastrointestinal pathogens in paediatric patients with diarrhoea during the COVID-19 pandemic in Spain: a multicentre molecular-based prospective study.

Alejandro Dashti, Carolina Hernández-Castro, Jin-Min Yuan, Sooria Balasegaram, Pamela Carolina Köster, Begoña Bailo, María Antonia Remacha, Rocío Martínez-Ruiz, Begoña Nogueira, Eva Ramírez de Arellano and 7 more

Abstract readMulticenter Study
In one paragraph

Article in European journal of pediatrics, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

17 authors.

Alejandro Dashti *Parasitology Reference and Research Laboratory, National Centre for Microbiology, Health Institute Carlos III, 28820, Majadahonda, Spain.ORCID http://orcid.org/0000-0001-8707-5731
Carolina Hernández-Castro *Parasitology Reference and Research Laboratory, National Centre for Microbiology, Health Institute Carlos III, 28820, Majadahonda, Spain.ORCID http://orcid.org/0000-0003-0731-6078
Jin-Min YuanField Service, UK Health Security Agency, London, UK.
Sooria BalasegaramField Service, UK Health Security Agency, London, UK.
Pamela Carolina KösterParasitology Reference and Research Laboratory, National Centre for Microbiology, Health Institute Carlos III, 28820, Majadahonda, Spain.ORCID http://orcid.org/0000-0001-5963-8824
Begoña BailoParasitology Reference and Research Laboratory, National Centre for Microbiology, Health Institute Carlos III, 28820, Majadahonda, Spain.ORCID http://orcid.org/0000-0002-9453-9431
María Antonia RemachaUniversity Health Care Complex of León, León, Spain.
Rocío Martínez-RuizHierro Majadahonda University Hospital, Majadahonda, Spain.
Begoña NogueiraRío Hortega University Hospital, Valladolid, Spain.
Eva Ramírez de ArellanoResistance to Antibiotics and Infections Related to Healthcare Reference and Research Laboratory, National Centre for Microbiology, Health Institute Carlos III, Majadahonda, Spain.ORCID http://orcid.org/0000-0002-8276-9731
Andrea LópezNational Centre for Microbiology, Health Institute Carlos III, Majadahonda, Spain.
María Teresa LlorenteSpecial Pathogens Reference and Research Laboratory, National Centre for Microbiology, Health Institute Carlos III, Majadahonda, Spain.ORCID http://orcid.org/0000-0002-4638-5386
Lourdes Castro-CompanioniParasitology Reference and Research Laboratory, National Centre for Microbiology, Health Institute Carlos III, 28820, Majadahonda, Spain.ORCID http://orcid.org/0009-0003-2746-4067
Nerea García-IbáñezEnterovirus and Viral Gastroenteritis Unit, National Centre for Microbiology, Health Institute Carlos III, Majadahonda, Spain.
María Dolores Fernández-GarcíaEnterovirus and Viral Gastroenteritis Unit, National Centre for Microbiology, Health Institute Carlos III, Majadahonda, Spain.ORCID http://orcid.org/0000-0003-0336-6596
David CarmenaParasitology Reference and Research Laboratory, National Centre for Microbiology, Health Institute Carlos III, 28820, Majadahonda, Spain. dacarmena@isciii.es.ORCID http://orcid.org/0000-0002-4015-8553
Sergio SánchezParasitology Reference and Research Laboratory, National Centre for Microbiology, Health Institute Carlos III, 28820, Majadahonda, Spain. sergio.sanchez@isciii.es.ORCID https://orcid.org/0000-0001-9903-6203

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Gastroenteritis is a major cause of morbidity in young children worldwide. A prospective multicentre study was conducted from September 2020 to September 2021 in three tertiary hospitals in Spain to assess the burden of the gastrointestinal pathogens causing paediatric gastroenteritis in different Spanish regions, to understand the impact of COVID-19 pandemic in their incidence, and to assess potential risk factors for infection. Stool samples from children aged 0-59 months with acute or chronic diarrhoea were analysed by PCR to detect and characterise gastrointestinal bacteria, parasites, and viruses. Whole-genome sequencing was carried out on enteroaggregative Escherichia coli isolates. Epidemiological and clinical data were analysed using univariable and multivariable logistic regression models. A total of 1114 children were included (median age, 16 months; 57.3% male). The most prevalent bacteria were enteropathogenic E. coli (16.0%) and Campylobacter spp. (15.0%). Giardia duodenalis (9.8%) and Cryptosporidium parvum (1.8%) were the most common parasites, while norovirus (5.5%) predominated among viruses. Molecular analyses revealed substantial genetic diversity across all pathogens. Campylobacter infection increased with age and was associated with fever and bloody diarrhoea, while norovirus infection decreased with age and was associated with vomiting.Conclusion COVID-19 countermeasures substantially altered the transmission of faecal-orally transmitted gastrointestinal pathogens in children, particularly reducing person-to-person spread of human-adapted pathogens such as C. hominis and endemic enteroaggregative E. coli subtypes. Zoonotic pathogens were largely unaffected, highlighting the selective impact of non-pharmaceutical interventions on anthroponotic transmission. What is Known: • Paediatric gastroenteritis is caused by faecal-orally transmitted viral, bacterial, and parasitic agents. • COVID-19 countermeasures contributed to the significant reduction of person-to-person transmitted gastrointestinal pathogens. What is New: • COVID-19 countermeasures drastically interrupted the person-to-person transmission of human-adapted Cryptosporidium hominis and endemic enteroaggregative Escherichia coli subtypes in Spanish children. • Cryptosporidium parvum and other zoonotically transmitted gastrointestinal pathogens were largely unaffected.

Indexed as

COVID-19DiarrheaGastroenteritisChild, PreschoolFecesFemaleHumansIncidenceInfantInfant, NewbornMalePandemicsProspective StudiesRisk FactorsSARS-CoV-2SpainChildrenGastroenteritisGastrointestinal pathogensGenotypingMolecular detectionRisk factors

Identifiers

PMID42390675
PMCPMC13328251

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.